RKLB Q2 Deep Dive: Iridium Acquisition, Neutron Progress, and Margin Pressures Shape Outlook

Aerospace and defense company Rocket Lab (NASDAQ:RKLB) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 62% year on year to $234.1 million. On top of that, next quarter’s revenue guidance ($257.5 million at the midpoint) was surprisingly good and 7% above what analysts were expecting. Its non-GAAP loss of $0.02 per share was 64.4% above analysts’ consensus estimates.

Is now the time to buy RKLB? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Rocket Lab’s Q2 performance reflected notable revenue growth, driven by strong momentum in its Space Systems segment and a surge in contract bookings from both government and commercial customers. Despite better-than-expected top line and non-GAAP earnings results, the market reacted negatively, with management attributing some margin pressure to integration costs from the Mynaric acquisition and a shift in business mix. CEO Peter Beck highlighted the company’s expanding backlog and key wins in satellite manufacturing, stating, “We achieved a record $234 million in Q2 revenue, up almost $90 million or 62% versus the same quarter last year.”

Looking ahead, Rocket Lab’s guidance is anchored by expectations of continued strength in satellite platforms and accelerating demand for launch services, particularly as Neutron nears its initial flights. Management emphasized the strategic significance of the pending Iridium acquisition, which CEO Peter Beck described as “the beginning of our new space applications era,” and noted that ongoing investment in Neutron’s development and production scaling will remain a central focus. CFO Adam Spice cautioned that elevated cash outflows are likely to persist until Neutron’s first successful test flight, after which the company expects to see a path toward adjusted EBITDA and, eventually, free cash flow positivity.

Key Insights from Management’s Remarks

Management credited the Q2 performance to robust contract wins in satellite platforms, progress on Neutron development, and strategic acquisitions, while also noting temporary margin pressures from recent M&A and changing revenue mix.

• Space Systems momentum: The Space Systems segment saw a significant increase in contract wins, highlighted by a $397 million satellite deal for the Space Force and new orders for Flatellite and GEO satellites, expanding Rocket Lab’s footprint in government and defense markets.

• Neutron development advances: Progress on the Neutron launch vehicle included final stage testing and key subsystem integrations, with management stressing that the focus is not only on achieving the first flight but also on rapidly scaling production to meet anticipated demand for subsequent launches.

• Pending Iridium acquisition: Rocket Lab announced its intention to acquire Iridium, aiming to vertically integrate launch, satellite manufacturing, and space applications. Beck noted this would position Rocket Lab as “a self-launching Tier 1 space power,” combining recurring revenue from Iridium’s communications network with Rocket Lab’s manufacturing and launch capabilities.

• Margin headwinds from integration: CFO Adam Spice said that the initial integration of Mynaric, which faced prior supply chain challenges and insolvency, contributed to lower gross margins in the quarter. Management expects margin improvement as synergies are realized and production volumes increase.

• Launch backlog at record levels: Demand for Electron, HASTE, and Neutron launches resulted in a record launch backlog, with over $437 million in new launch bookings and expanded launch site capabilities, including the deployment of GHOST containerized launch infrastructure to address flexible government needs.

Drivers of Future Performance

Rocket Lab’s outlook for the coming quarters is driven by strong demand for satellite platforms, increased launch cadence, and the anticipated benefits from vertical integration following the Iridium acquisition.

• Neutron scaling and demand: Management highlighted the importance of moving beyond Neutron’s first launch to rapidly achieve a steady flight cadence, citing extreme industry-wide launch constraints. CFO Adam Spice stated that demand for Neutron is “not a concern,” and that careful customer selection will be key as capacity remains limited.

• Iridium integration and applications growth: The pending Iridium acquisition is expected to accelerate Rocket Lab’s entry into the space applications market, enabling new offerings in areas such as IoT (Internet of Things), direct-to-device, and safety-critical communications. Management believes the combination will unlock new government and commercial opportunities by leveraging Iridium’s existing subscriber base and spectrum.

• Margin recovery and investment cycle: Management anticipates ongoing elevated operating expenses and negative free cash flow until Neutron’s test flight and full-scale production ramp. However, once these milestones are reached, adjusted EBITDA and cash flow are expected to improve, bolstered by the integration of Mynaric and future contributions from Iridium.

Catalysts in Upcoming Quarters

In the upcoming quarters, our analyst team will closely track (1) the pace of Neutron’s development and the timing of its first flight, (2) integration milestones and early performance metrics from the Mynaric and pending Iridium acquisitions, and (3) the conversion of Rocket Lab’s expanding contract backlog into realized revenue. We will also monitor progress on new product rollouts, such as Flatellite and GHOST infrastructure, as key indicators of execution against management’s growth strategy.

Rocket Lab currently trades at $78.93, down from $80.41 just before the earnings. Is there an opportunity in the stock? The answer lies in our full research report (it’s free).

Stocks That Trumped Tariffs

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.